FutuRx biotech incubator selects first two projects

The two startups are XoNovo (Alzheimer's Disease) and Hepy Biosciences (cancer).

Dr. Rafi Gidron, cofounder of Chromatis, sold in 2000 for $4.2 billion, who is currently chairman of Israel Brain Technologies, founded by former President Shimon Peres, is officially switching to biomed.

Gidron has also begun practicing entrepreneurship by founding XoNovo, which treats Alzheimer's Disease and other diseases involving brain degeneration. The company has entered the Chief Scientist's FutuRx biotechnology incubator, operated by franchise holders OrbiMed Advisors LLC, pharmaceutical giant Johnson and Johnson (through the JJDC investment fund), and Takeda Pharmaceutical.

XoNovo was founded on the basis of technology from the Oklahoma Medical Research Foundation in the US. The molecule has already passed clinical trials on animals, and it was found that it improves the state of animals with diseases similar to Alzheimer's and ALS. Among animals with Alzheimer's Disease, the drug reduced both cognitive degeneration and the accumulation in the brain of materials associated with the disease.

In the first stage, XoNovo will treat Alzheimer's Diseas and Batten, an orphan disease. Dr. Liora Braiman-Wiksman will manage XoNovo. There have been many failures in treatments for Alzheimer's Disease in recent years, but the company is encouraged because the operating mechanism of its drug is new - it attacks a protein named CRMP2, which up until now has not been the target of any drug that has been tried unsuccessfully.

Another company in which the incubator is investing is Hepy Biosciences, which is developing a cancer drug that suppresses a certain enzyme in the tumor essential for its growth and for the development of secondary tumors. In the first stage, a product for lung cancer and pancreatic cancer will be developed. The drug is based on research by Prof. Israel Vlodavsky at the Rappaport Family Institute for Research in the Medical Sciences at the Technion Israel Institute of Technology and the oncology department at the Hadassah Medical Center. Another partner in founding the company is Prof. Oded Livnah, director of the Wolfson Center for Applied Structural Biology at the Hebrew University of Jerusalem. Dr. Nili Schutz will manage the company.

These two pharmaceutical companies are in the early stages, which are not yet suitable for a venture capital fund in the sector, but the franchise holders believe that they have great potential.

FutuRX CEO Einat Zisman says, "I believe that through the incubator, the companies will become leaders making a significant contribution to the development of medical technology for the benefit of patients." Anya Eldan, GM Incubator Program at the Office of the Chief Scientist, said, "The biotech incubator program enables each incubator company that meets milestones to obtain over NIS 8 million in financing over three years. The state provides 85% of the budget, and the incubator finances the rest, thereby facilitating investment in high-risk companies, which otherwise would be unable to obtain financing. This structure will help consolidate the bio-pharma industry in Israel."

Published by Globes [online], Israel business news - www.globes-online.com - on January 14, 2015

© Copyright of Globes Publisher Itonut (1983) Ltd. 2015

Intel's 2025 vision credit: Intel Will Intel's sell-off include Israeli assets?

After the sale of Altera, "Globes" considers whether the troubled chipmaker will sell Mobileye or its Kiryat Gat fab.

CloudShare management team credit: PR Bow River Capital buys Israeli co CloudShare

The Denver-based alternative asset manager is paying an estimated $60-80 million for the SaaS provider of AI guided solutions for complex technical training requirements.

Housing prices continue to rise   credit: Tali Bogdanovsky Israel's housing price rise riddle

Despite a huge inventory of unsold new homes in central Israel and weak sales, apartment prices are still rising. "Globes" analyzes the data.

Inflation  credit: Tali Bogdanovsky March CPI higher than expected, housing prices rise

The March reading brings annual inflation in Israel down to 3.3% from 3.4% at the end of February.

Ben Gurion airport credit: Tali Bogdanovsky Abundance of affordable last minute Passover flight deals

The return of foreign airlines to Israel has brought down fares dramatically even for last minute vacations.

Karish rig  credit: Eyal Izhar Kesem Energy signs gas deals worth $2.8b

The power plant, scheduled to begin operating in 2029, will buy gas worth $2 billion from Energean and a further $700-800 million from the Tamar partners.

Kosher for Passover Coca Cola bottles credit: social media Why are yellow cap Coca Cola bottles different from all others?

Nostalgic Coca Cola aficionados claim that the kosher for Passover version, made from sugar cane instead of high fructose corn syrup, is the genuine taste of the soft drink.

Avigdor Willenz credit: Intel Exclusive: Avigdor Willenz's Element Labs raises $50m

The Israeli startup is developing AI processors for inference, the stage in which AI models are activated after they have already been trained.

Ilya Sutskever credit: Cadya Levy SSI hiring dozens in Israel

AI company Safe Superintelligence is hiring many dozens of people in Tel Aviv, "Globes" has learned.

Johny Srouji credit: Amos Ben Gershom GPO Apple SVP leads senior delegation of execs to Israel

Jony Srouji: I am always filled with renewed energy and optimism about our shared achievements when I visit our R&D centers here.

Israeli apartments Credit: Shutterstock Apartments sold and rented

A selection of recent real estate deals in Israel in Tel Aviv, Ramat Gan, Petah Tikva, Givat Shmuel, Tiberias and Dimona.

Infinity Tower Tel Aviv credit: Courtesy Hagag Group French investors buy 2 Tel Aviv apartments for NIS 27.5m

The two apartments are in Hagag Group's Infinity Tower in the Summeil district.

El Al plane credit: Shutterstock El Al receives state approval to distribute dividend

The Israeli airline has now announced that it will be able to distribute up to 30% of net profit in 2025 and up to 40% in 2026-2028.

groundcover founders credit: Yossi Yarom Israeli observability co groundcover raises $35m

groundcover has developed a “Bring Your Own Cloud” (BYOC) observability solution, redefining the architecture of a modern observability platform.

Tel Aviv Stock Exchange credit: Shutterstock MagioreStock Foreign investment in TASE hits five-year high

Foreign investors have been flocking to the Tel Aviv Stock Exchange in recent weeks, the TASE research department tells "Globes."

Elbit Systems tank turret systems credit: Elbit Systems Elbit Systems wins $100m tank turret systems deal

The Israel defense electronics company will supply its advanced UT30 MK2 unmanned turret systems to General Dynamics European Land Systems (GDELS) to be supplied to a NATO European country.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018